Loading organizations...
Drads Capital operates as an active advisor and investor, providing strategic support and opportunities for advancement to its portfolio companies. The firm focuses on fostering strong management teams by lending expertise for the execution of fruitful business and financial strategies, extending beyond conventional capital investment. Its portfolio includes companies specializing in areas such as organ regeneration, precision fermentation, and AI-driven healthcare solutions, indicating a clear focus on deep technology and life sciences.
The firm was founded by A. Nagarajan Pillay, also known as Rajan Pillay, a seasoned entrepreneur with over two and a half decades of experience. Pillay's insight was to create an investment vehicle that not only provides financial backing but also actively engages with its ventures through dedicated advisory and strategic guidance, leveraging his extensive background to accelerate their development.
Drads Capital serves entrepreneurs and nascent companies within its specialized sectors, offering them unparalleled access to resources and guidance. The firm's long-term vision centers on cultivating robust management structures and contributing to a healthier future by supporting innovative companies that address significant challenges in biotechnology and artificial intelligence.
Key people at Drads Capital.
Drads Capital was founded in 2018 by Shaun Patel (Co-Founder and Partner) and Rudolph Tanzi (Co-Founder).
Drads Capital was founded in 2018 by Shaun Patel (Co-Founder and Partner) and Rudolph Tanzi (Co-Founder).
Drads Capital has 1 tracked investment across 1 company. The latest tracked deal is $26.3M Series C in AZTherapies in October 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 17, 2019 | AZTherapies | $26.3M Series C | Cosine, TAS Parafestas | IBS Capital, Wexford Capital |
Key people at Drads Capital.